Urte Gayko

Urte Gayko is a highly experienced professional in the pharmaceutical industry, with a background in regulatory affairs and drug development. They have held various leadership roles at companies such as Summit Therapeutics, Nektar Therapeutics, Pharmacyclics LLC, Nodality Inc., and Amgen. With a PhD in Molecular and Cellular Biology from Harvard University, they have demonstrated expertise in regulatory drug development, with a focus on oncology and autoimmune diseases.